Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)

National Institutes of Health

MODERATE Tx General

Strategy Notes

—

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: —
Cycle: —
Amount: —
Type: grant
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-22 OPEN → INELIGIBLE · NIH U01 grants require a sponsoring institution (U.S. or foreign) and a principal investigator with an institutional affiliation; the applicant is an independent researcher with no qualifying institution.